ONTAK® Sensitivity (CD25)

The ONTAK® Sensitivity (CD25) test contains 1 test with 3 biomarkers.

ONTAK® is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL) with malignant cells that express CD25. Pretreatment testing to establish CD25 sensitivity is available.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: ONTAK Sensitivity CD25

Viability:

Sample Description:

Result: